Ansbert Gadicke, Director, 10% Owner at Cullinan Oncology, Inc. (CGEM), sold 51,619 shares at $29.10 ($1.5M) on 2021-09-13, disclosed to the SEC on 2021-09-13.
Open-market sale of $1.5M CGEM by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.35 | 1,898 | $56K | 3.7% |
| 2 | $29.35 | 1,898 | $56K | 3.7% |
| 3 | $29.35 | 13,727 | $403K | 26.7% |
| 4 | $29.35 | 13,727 | $403K | 26.7% |
| 5 | $29.04 | 820 | $24K | 1.6% |
| 6 | $29.04 | 5,931 |
| $172K |
| 11.4% |
| 7 | $29.04 | 5,931 | $172K | 11.4% |
| 8 | $29.10 | 497 | $14K | 1.0% |
| 9 | $29.10 | 3,595 | $105K | 6.9% |
| 10 | $29.10 | 3,595 | $105K | 6.9% |
| Total | $29.24 avg | 51,619 | $1.5M | 100% |
| Filing → |
| ITOS | SELL | 2022-01-06 | $20.9M | — | Filing → |
| ITOS | SELL | 2021-10-14 | $5.2M | — | Filing → |
| ITOS | SELL | 2021-10-05 | $2.2M | — | Filing → |